The Walden Group Releases Q3 2022 Strategic Healthcare M&A Report

The Walden Group is pleased to provide access to its Q3 2022 Strategic Healthcare M&A Report, which includes:

•       Market Overview -- What you need to know about MDR and more
•       Major M&A Deals by Sector
•       For Ophthalmology, Orthopedic & Spine, and Woundcare - Key Developments and Deals
•       Key Stats on Top M&A Deals in Q3 2022
•       Performance of Leading Healthcare Companies
•       Analysis of More Than 60 Q3 M&A Transactions

Click here to download the Report.